-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In recent years, the pharmaceutical industry policy has been continuously introduced, consistent evaluation, China's accession to ICH, MAH implementation, drug clinical trial data verification and other accelerated industry survival of the fittest;
the reform of medical policy, the development of China's pharmaceutical industry is stepping into the fast track of norms.
the background of "healthy China" rising as a national strategy, China is undergoing the transformation from "medical power" to "medical power".
as one of the seven strategic emerging industries in China, biopharmaceutical industry is becoming a new engine of China's economic development.
through policy regulation, investment of supporting resources and perfection of institutional mechanism construction, China's biopharmaceutical industry has transitioned from "technological backwardness" to "following the international pace", in which the development of innovative drugs is particularly rapid.
a number of innovative biopharmaceutical companies, such as Baiji Shenzhou, Xinda Bio, Junshi Bio, etc., as well as independent research and development of innovative drugs have been approved for market.
to maintain rapid growth, we need more top talent to join and improve the overall level of practitioners.
For innovative drug practitioners to provide a free and smooth exchange platform, Sina Pharmaceuticals in particular launched the "New Zhihui" online live knowledge sharing platform, will focus on drug research and development target discovery, new technology development and application, process development and verification, drug clinical trial design and other hot topics, through strategy and case sharing, directly hit the confusion in research and development production.
Course Highlights: 1, keep up with trends, share new technology development and application, 2, dry goods, focus on case sharing and method analysis, 3, pay tribute to innovation, pay tribute to medical people, 4, the course is open, everyone can become a product manager, your valuable suggestions for live content is our ability to improve, excellent you can apply to become a course instructor.
Thursday, August 6th, the 5th lesson of "New Zhihui" will be held, and Cytiva China's Cell Culture Process Science Leader, Dr. Xiaokai, will share with you the "High Density Irrigation Cell Culture Process Establishment and Amplification Considerations" and look forward to your participation.
Shasing Topics: High Density Irrigation Cell Culture Process Establishment and Amplification Consideration Elements1. Irrigation Cell Culture Process Introduction 2. Irrigation Cell Culture Process Establishment and Amplification Consideration Elements 3. High Density Irrigation Cell Culture Process Solutions Presenter: Dr. Cytiva Cytiva China Cell Culture Process Science Leader Live Time: August 6, 2020 19:30-20:30 Presenter Cytiva China Dr. CellCulture Process Science Leader Gilling University Ph.D., Molecular Immunology, University of New South Wales, Australia.
joined Cytiva, he worked for Biopharmaceuticals, Antibody Drug Development CRO/CDMO, Thermo Bio.
years of experience in the development of biopharmaceutical upstream processes.
registration: this course is free, scan the two-dimensional code to fill in the registration information, live broadcast day by mail link, or click here link to register: